| Trial ID: | L4668 |
| Source ID: | NCT00704223
|
| Associated Drug: |
Biphasic Insulin Aspart
|
| Title: |
Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes
|
| Acronym: |
INTENSIV
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic insulin aspart
|
| Outcome Measures: |
Primary: number of major and minor hypoglycaemic events and adverse events, 3 months | Secondary: HbA1c, 3 months|PPBG, 3 months|FBG, 3 months
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
619
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-05
|
| Completion Date: |
2008-11
|
| Results First Posted: |
|
| Last Update Posted: |
2014-06-24
|
| Locations: |
Wien, 1140, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT00704223
|
